William Blair

Excalibur invests in companies located in the United Kingdom. The firm targets companies operating in the fields of biotechnology and medical devices. It provide financing for mezzanine, seed, early and later stage capital requirements.

Adamant Ventures is an active manager which invests in companies in the healthcare sector, including pharmaceuticals, biotech, medtech, generics and services. Their geographic focus is on the UK, Scandinavia, Central Europe and the US. The firm invests based on stock picking, sub-sector weightings and geographical allocation. They perform fundamental research and leverage their network of scientists, doctors and financial experts to profit from the growth of the biomedical market. Demographics and medical breakthroughs are the major factors influencing their investment approach.

Provides debt and equity funding services

Provides clinical development services for antibody-drug conjugate

Designs, manufactures and sells noble gas polarizer devices & ancillary instruments

Provides investment services